During the past decade, Hopital Augustin Morvan; Hematologie conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital Augustin Morvan; Hematologie" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "Merck Sharp & Dohme LLC" with 2 trials sponsored, "University Hospital, Bordeaux" with 2 trials sponsored and "Centre Hospitalier Annecy Genevois" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Augustin Morvan; Hematologie" #1 collaborator was "ADIR, a Servier Group company" with 1 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator and "Eisai Inc." with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Augustin Morvan; Hematologie" are "Non-Hodgkin's Lymphoma" (2 trials), "Acute Myeloid Leukemia" (1 trials), "Bone Metastases" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Carcinoma, Ovarian Epithelial" (1 trials). Many other conditions were trialed in "Hopital Augustin Morvan; Hematologie" in a lesser frequency.

Most popular intervention types in "Hopital Augustin Morvan; Hematologie" are "Drug" (16 trials), "Biological" (3 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (3 trials), "Paclitaxel" (3 trials), "Atezolizumab" (2 trials), "Bendamustine" (2 trials) and "Bevacizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Augustin Morvan; Hematologie" are 15 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hopital Augustin Morvan; Hematologie". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Hopital Augustin Morvan; Hematologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Augustin Morvan; Hematologie, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".